- Location
solid tumor
"-
Sunesis Pharmaceuticals Has Expanded Its Hematology Franchise
Jan 13, 2014Sunesis Pharmaceuticals has expanded its hematology franchise through separate global licensing agreements for two preclinical kinase inhibitor programs. The first agreement, with Biogen Idec, is for global commercial rights to SNS-062, a ...
Tags: Sunesis Pharmaceuticals, Medicine
-
Sutro Biopharma Has Entered Into a Collaboration Agreement
Jan 8, 2014Sutro Biopharma, a biopharmaceutical company developing a new generation of protein therapeutics, including next-generation antibody drug conjugates and bispecific antibodies, today announced that it has entered into a collaboration ...
Tags: Bispecific Antibodies, Sutro's Cell-Free Protein Synthesis Technology
-
BBC TV Can Be Seen at HTTP://Www.Bbc.Co.UK/News/Health-25499045
Jan 2, 2014Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network ...
-
BIND Therapeutics Amended Its Development and Commercialization Collaboration Agreement
Dec 16, 2013BIND Therapeutics, a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, has amended its development and commercialization collaboration agreement with Amgen to extend the period ...
-
Analytic Validation Study'Publication of Foundationone Is Reported by Foundation Medicine
Oct 22, 2013Foundation Medicine, molecular information company, has announced that results from a 24-month, multi-institution collaboration demonstrating the analytic validation of its cancer genomic profiling assay, FoundationOne, were published in ...
Tags: Foundation Medicine
-
Affymetrix Launched OncoScan FFPE Assay Kit at Chicago
Aug 6, 2013Affymetrix has launched a whole-genome copy number assay for highly degraded FFPE solid tumor samples, called OncoScan FFPE assay kit, at Chicago. The new OncoScan FFPE assay kit with its unique molecular inversion probe (MIP) technology ...
Tags: Affymetr, FFPE solid tumor samples
-
Diagnostic Test for Arno Partner Veridex Developed a Tumor Cells
Jun 4, 2013US-based company Arno has entered into partnership with Veridex, a Johnson & Johnson company, to develop a diagnostic test that detects the presence of activated progesterone receptors (APRs) as a biomarker of anti-progestin activity in ...
Tags: Arno, Diagnostic Test
-
Magforce Nanotherm Therapy Will Be Distributed by Tek Grup
Dec 18, 2012Tek Grup has entered into an agreement to distribute MagForce's NanoTherm therapy in Turkey, Albania, Iraq and Azerbaijan. The NanoTherm therapy is designed for the local treatment of solid tumors. As per the agreement, Tek Grup ...
Tags: Tek Grup, NanoTherm therapy, medical service, solid tumor
-
OncoSec Medical Has Obtained CE Certification to Treat Solid Tumor Cancers
Dec 18, 2012OncoSec Medical has obtained CE certification for its proprietary gene and drug delivery technology, designed to treat solid tumor cancers. The assessment and certification process was supervised by SGS Group, a provider of inspection, ...
Tags: OncoSec, CE certification, proprietary gene, drug delivery technology
